Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake

BackgroundHuman papillomavirus (HPV) vaccinations protect against HPV infections. The infection might lead to vaginal cancer, vulvar cancer, genital warts, cervical intraepithelial neoplasia lesions, and cervical cancer. This study assessed hesitancy of HPV vaccination, associated factors, and barri...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashenafi Kibret Sendekie, Biruk Beletew Abate, Betelhem Anteneh Adamu, Aschalew Mulatu Tefera, Kaleab Temelket Mekonnen, Melkam Alemu Ashagrie, Yabibal Berie Tadesse, Abera Dessie Dagnaw, Mequannent Sharew Melaku, Gizachew Kassahun Bizuneh
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2025.1507832/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591049993748480
author Ashenafi Kibret Sendekie
Ashenafi Kibret Sendekie
Biruk Beletew Abate
Biruk Beletew Abate
Betelhem Anteneh Adamu
Aschalew Mulatu Tefera
Kaleab Temelket Mekonnen
Melkam Alemu Ashagrie
Yabibal Berie Tadesse
Abera Dessie Dagnaw
Mequannent Sharew Melaku
Gizachew Kassahun Bizuneh
author_facet Ashenafi Kibret Sendekie
Ashenafi Kibret Sendekie
Biruk Beletew Abate
Biruk Beletew Abate
Betelhem Anteneh Adamu
Aschalew Mulatu Tefera
Kaleab Temelket Mekonnen
Melkam Alemu Ashagrie
Yabibal Berie Tadesse
Abera Dessie Dagnaw
Mequannent Sharew Melaku
Gizachew Kassahun Bizuneh
author_sort Ashenafi Kibret Sendekie
collection DOAJ
description BackgroundHuman papillomavirus (HPV) vaccinations protect against HPV infections. The infection might lead to vaginal cancer, vulvar cancer, genital warts, cervical intraepithelial neoplasia lesions, and cervical cancer. This study assessed hesitancy of HPV vaccination, associated factors, and barriers to vaccination among youth girls in Ethiopia.MethodsAn institutional-based cross-sectional study was conducted among female undergraduate students at the University of Gondar, College of Medicine and Health Sciences, between July and August 2022. The data was collected using a self-administered questionnaire. A simple random sampling method was used to recruit participants. The data were entered and analyzed with SPSS version 26. Descriptive statistics were used to describe the participants’ demographic characteristics. Logistic regression was performed to identify the significant factors associated with acceptance of the HPV vaccine. A p-value <0.05 was considered statistically significant.ResultsThe study included 423 participants with a mean age of 22.5 ± 6.7 years. Only more than one-third (35.2, 95% CI: 27.2–44.1) received the HPV vaccine. Currently, more than one-fourth (27.9, 95% Cl: 21.4–33.8) of participants are hesitant to receive the HPV vaccine. Higher monthly income (AOR = 1.52, 95% CI: 1.08–6.34), good knowledge of the HPV vaccine (AOR = 2.12, 95% CI: 1.12–4.87), and a positive attitude towards the vaccine (AOR = 3.03, 95% CI: 1.63–9.56) were significantly associated with acceptance of HPV vaccination. Safety concerns (63.1%), misinformation (42.8%), and parental concerns (42.3%) about the HPV vaccine were among the top perceived reported barriers to receiving the HPV vaccine.ConclusionThis result showed that more than a quarter number of youth girls are still hesitant to receive HPV vaccinations. To increase vaccination acceptance, interventions should focus on awareness-raising programs about HPV infection and vaccines and addressing safety and parental concerns.
format Article
id doaj-art-a6023dd964b044a68f119a70c9c18e0e
institution Kabale University
issn 2296-2565
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj-art-a6023dd964b044a68f119a70c9c18e0e2025-01-23T05:10:24ZengFrontiers Media S.A.Frontiers in Public Health2296-25652025-01-011310.3389/fpubh.2025.15078321507832Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptakeAshenafi Kibret Sendekie0Ashenafi Kibret Sendekie1Biruk Beletew Abate2Biruk Beletew Abate3Betelhem Anteneh Adamu4Aschalew Mulatu Tefera5Kaleab Temelket Mekonnen6Melkam Alemu Ashagrie7Yabibal Berie Tadesse8Abera Dessie Dagnaw9Mequannent Sharew Melaku10Gizachew Kassahun Bizuneh11Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaSchool of Pharmacy, Curtin Medical School, Faculty of Health Sciences, Curtin University, Bentley, WA, AustraliaCollege of Medicine and Health Sciences, Woldia University, Woldia, EthiopiaSchool of Population Health, Curtin University, Bentley, WA, AustraliaDepartement of Pharmacognosy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaDepartement of Pharmacognosy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaDepartement of Pharmacognosy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaDepartement of Pharmacognosy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaDepartment of Pharmaceutical Chemistry, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaDepartment of Pharmaceutical Chemistry, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaDepartment of Health Informatics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaDepartement of Pharmacognosy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaBackgroundHuman papillomavirus (HPV) vaccinations protect against HPV infections. The infection might lead to vaginal cancer, vulvar cancer, genital warts, cervical intraepithelial neoplasia lesions, and cervical cancer. This study assessed hesitancy of HPV vaccination, associated factors, and barriers to vaccination among youth girls in Ethiopia.MethodsAn institutional-based cross-sectional study was conducted among female undergraduate students at the University of Gondar, College of Medicine and Health Sciences, between July and August 2022. The data was collected using a self-administered questionnaire. A simple random sampling method was used to recruit participants. The data were entered and analyzed with SPSS version 26. Descriptive statistics were used to describe the participants’ demographic characteristics. Logistic regression was performed to identify the significant factors associated with acceptance of the HPV vaccine. A p-value <0.05 was considered statistically significant.ResultsThe study included 423 participants with a mean age of 22.5 ± 6.7 years. Only more than one-third (35.2, 95% CI: 27.2–44.1) received the HPV vaccine. Currently, more than one-fourth (27.9, 95% Cl: 21.4–33.8) of participants are hesitant to receive the HPV vaccine. Higher monthly income (AOR = 1.52, 95% CI: 1.08–6.34), good knowledge of the HPV vaccine (AOR = 2.12, 95% CI: 1.12–4.87), and a positive attitude towards the vaccine (AOR = 3.03, 95% CI: 1.63–9.56) were significantly associated with acceptance of HPV vaccination. Safety concerns (63.1%), misinformation (42.8%), and parental concerns (42.3%) about the HPV vaccine were among the top perceived reported barriers to receiving the HPV vaccine.ConclusionThis result showed that more than a quarter number of youth girls are still hesitant to receive HPV vaccinations. To increase vaccination acceptance, interventions should focus on awareness-raising programs about HPV infection and vaccines and addressing safety and parental concerns.https://www.frontiersin.org/articles/10.3389/fpubh.2025.1507832/fullHuman papillomavirusHPV vaccinevaccine hesitancyvaccination acceptanceknowledgeattitude
spellingShingle Ashenafi Kibret Sendekie
Ashenafi Kibret Sendekie
Biruk Beletew Abate
Biruk Beletew Abate
Betelhem Anteneh Adamu
Aschalew Mulatu Tefera
Kaleab Temelket Mekonnen
Melkam Alemu Ashagrie
Yabibal Berie Tadesse
Abera Dessie Dagnaw
Mequannent Sharew Melaku
Gizachew Kassahun Bizuneh
Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
Frontiers in Public Health
Human papillomavirus
HPV vaccine
vaccine hesitancy
vaccination acceptance
knowledge
attitude
title Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
title_full Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
title_fullStr Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
title_full_unstemmed Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
title_short Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
title_sort human papillomavirus vaccination hesitancy among young girls in ethiopia factors and barriers to uptake
topic Human papillomavirus
HPV vaccine
vaccine hesitancy
vaccination acceptance
knowledge
attitude
url https://www.frontiersin.org/articles/10.3389/fpubh.2025.1507832/full
work_keys_str_mv AT ashenafikibretsendekie humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT ashenafikibretsendekie humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT birukbeletewabate humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT birukbeletewabate humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT betelhemantenehadamu humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT aschalewmulatutefera humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT kaleabtemelketmekonnen humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT melkamalemuashagrie humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT yabibalberietadesse humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT aberadessiedagnaw humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT mequannentsharewmelaku humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake
AT gizachewkassahunbizuneh humanpapillomavirusvaccinationhesitancyamongyounggirlsinethiopiafactorsandbarrierstouptake